| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BCP.2007.05.023 |
| P698 | PubMed publication ID | 17597586 |
| P50 | author | Michele Zoli | Q42498009 |
| P2093 | author name string | Cecilia Gotti | |
| Annalisa Gaimarri | |||
| Milena Moretti | |||
| Alessio Zanardi | |||
| Franceso Clementi | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heterogeneity | Q928498 |
| P304 | page(s) | 1102-1111 | |
| P577 | publication date | 2007-06-02 | |
| P1433 | published in | Biochemical Pharmacology | Q864229 |
| P1476 | title | Heterogeneity and complexity of native brain nicotinic receptors | |
| P478 | volume | 74 |
| Q43236757 | A conserved cysteine residue in the third transmembrane domain is essential for homomeric 5-HT3 receptor function |
| Q34846533 | A portable site: a binding element for 17β-estradiol can be placed on any subunit of a nicotinic α4β2 receptor |
| Q34172963 | A transcriptional regulatory element critical for CHRNB4 promoter activity in vivo |
| Q34458445 | Acetylcholine Receptor (AChR) α5 Subunit Variant Associated with Risk for Nicotine Dependence and Lung Cancer Reduces (α4β2)2α5 AChR Function |
| Q36807622 | Activation of the α7 nicotinic ACh receptor induces anxiogenic effects in rats which is blocked by a 5-HT₁a receptor antagonist |
| Q39061997 | Acute activation, desensitization and smoldering activation of human acetylcholine receptors |
| Q36573029 | Adolescent nicotine exposure transiently increases high-affinity nicotinic receptors and modulates inhibitory synaptic transmission in rat medial prefrontal cortex |
| Q34958405 | Alanine scan of α-conotoxin RegIIA reveals a selective α3β4 nicotinic acetylcholine receptor antagonist. |
| Q27345275 | Alcohol and nicotine interactions: pre-clinical models of dependence |
| Q34078196 | Alpha 7 subunit of nAChR regulates migration of human mesenchymal stem cells |
| Q24307995 | Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking |
| Q37125192 | Alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators. |
| Q92402680 | Alzheimer's Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts |
| Q37334917 | An ER-resident membrane protein complex regulates nicotinic acetylcholine receptor subunit composition at the synapse |
| Q35181919 | An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants |
| Q33883659 | Association of CHRN genes with "dizziness" to tobacco |
| Q41636544 | Associations of rare nicotinic cholinergic receptor gene variants to nicotine and alcohol dependence |
| Q28477330 | Blockade of neuronal α7-nAChR by α-conotoxin ImI explained by computational scanning and energy calculations |
| Q46345641 | Brain activation by short-term nicotine exposure in anesthetized wild-type and beta2-nicotinic receptors knockout mice: a BOLD fMRI study. |
| Q36111331 | CHRNB2 promoter region: association with subjective effects to nicotine and gene expression differences |
| Q36973272 | Characterization of a multiple ligand-gated ion channel cellular membrane affinity chromatography column and identification of endogenously expressed receptors in astrocytoma cell lines |
| Q35117369 | Cholinergic modulation of angiogenesis: role of the 7 nicotinic acetylcholine receptor. |
| Q34139537 | Cholinergic modulation of neuronal excitability in the accessory olfactory bulb. |
| Q48609200 | Cognitive Effects of Nicotine: Recent Progress |
| Q30474904 | Cognitive effects of nicotine: genetic moderators |
| Q35181132 | Contributions of β2 subunit-containing nAChRs to chronic nicotine-induced alterations in cognitive flexibility in mice |
| Q48510136 | Cracking the Betel Nut: Cholinergic Activity of Areca Alkaloids and Related Compounds |
| Q64074559 | Crystal Structure of the Monomeric Extracellular Domain of α9 Nicotinic Receptor Subunit in Complex With α-Conotoxin RgIA: Molecular Dynamics Insights Into RgIA Binding to α9α10 Nicotinic Receptors |
| Q43178185 | Demonstration of functional alpha4-containing nicotinic receptors in the medial habenula |
| Q34167942 | Design, synthesis, and pharmacological characterization of novel spirocyclic quinuclidinyl-Δ2-isoxazoline derivatives as potent and selective agonists of α7 nicotinic acetylcholine receptors |
| Q37995815 | Development of the motivational system during adolescence, and its sensitivity to disruption by nicotine. |
| Q37535489 | Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions |
| Q35108773 | Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment |
| Q27676607 | Dimeric -Cobratoxin X-ray Structure: LOCALIZATION OF INTERMOLECULAR DISULFIDES AND POSSIBLE MODE OF BINDING TO NICOTINIC ACETYLCHOLINE RECEPTORS |
| Q38204497 | Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation |
| Q36850568 | Effects of chronic buspirone treatment on nicotine and concurrent nicotine+cocaine self-administration |
| Q37642452 | Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration |
| Q33636887 | Engineering neuronal nicotinic acetylcholine receptors with functional sensitivity to alpha-bungarotoxin: a novel alpha3-knock-in mouse |
| Q37018495 | Epibatidine application in vitro blocks retinal waves without silencing all retinal ganglion cell action potentials in developing retina of the mouse and ferret |
| Q34458500 | Expression of Functional Human α6β2β3* Acetylcholine Receptors in Xenopus laevis Oocytes Achieved through Subunit Chimeras and Concatamers |
| Q28487793 | Fluorescence-based high-throughput functional profiling of ligand-gated ion channels at the level of single cells |
| Q33578294 | Functional characterization improves associations between rare non-synonymous variants in CHRNB4 and smoking behavior |
| Q46365543 | Functional expression of nicotinic acetylcholine receptors in rat neocortical layer 5 pyramidal cells |
| Q37150553 | Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments |
| Q48094212 | Imaging α4β2 Nicotinic Acetylcholine Receptors (nAChRs) in Baboons with [18F]XTRA, a Radioligand with Improved Specific Binding in Extra-Thalamic Regions. |
| Q38741215 | Impact of ageing on postsynaptic neuronal nicotinic neurotransmission in auditory thalamus |
| Q40954873 | Impact of human D398N single nucleotide polymorphism on intracellular calcium response mediated by α3β4α5 nicotinic acetylcholine receptors |
| Q44959002 | Impact of neuro-psychological factors on smoking-associated lung cancer |
| Q37326725 | In vivo effects of 3-iodocytisine: pharmacological and genetic analysis of hypothermia and evaluation of chronic treatment on nicotinic binding sites |
| Q40111690 | Insights into nicotinic receptor signaling in nicotine addiction: Implications for prevention and treatment. |
| Q89259836 | Knockout of alpha 5 nicotinic acetylcholine receptors subunit alters ethanol-mediated behavioral effects and reward in mice |
| Q50023885 | Layer- and Cell Type-Specific Modulation of Excitatory Neuronal Activity in the Neocortex |
| Q47177367 | Levamisole: A Positive Allosteric Modulator for the α3β4 Nicotinic Acetylcholine Receptors Prevents Weight Gain in the CD-1 Mice on a High Fat Diet |
| Q39850502 | Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and function |
| Q92177749 | Minimal Structural Changes Determine Full and Partial Nicotinic Receptor Agonist Activity for Nicotine Analogues |
| Q37508580 | Modeling nicotinic neuromodulation from global functional and network levels to nAChR based mechanisms |
| Q36208114 | Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA. |
| Q35531867 | Molecular interaction of α-conotoxin RgIA with the rat α9α10 nicotinic acetylcholine receptor |
| Q22252514 | Multiple roles for nicotine in Parkinson's disease |
| Q35566709 | Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses |
| Q34342747 | Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence |
| Q36137598 | Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions |
| Q37381294 | Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability |
| Q37180827 | Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys |
| Q37294509 | Nicotine self-medication of cognitive-attentional processing |
| Q36851620 | Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation |
| Q48618313 | Nicotinic cholinergic and dopaminergic receptor mRNA expression in male and female rats with high or low preference for nicotine. |
| Q30372351 | Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders |
| Q28087047 | Nicotinic receptor modulation to treat alcohol and drug dependence |
| Q38345699 | Nicotinic receptors and attention |
| Q36828916 | Nicotinic receptors in neurodegeneration |
| Q37590093 | Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system |
| Q39136644 | Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors |
| Q34661812 | Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats |
| Q37395740 | Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes |
| Q38193225 | Pharmacological chaperoning of nAChRs: a therapeutic target for Parkinson's disease. |
| Q35996739 | Pharmacological chaperoning of nicotinic acetylcholine receptors reduces the endoplasmic reticulum stress response. |
| Q28547248 | Positive Selection on Loci Associated with Drug and Alcohol Dependence |
| Q35873352 | Potentiation of Neuronal Nicotinic Receptors by 17β-Estradiol: Roles of the Carboxy-Terminal and the Amino-Terminal Extracellular Domains |
| Q37976289 | Prefrontal neuromodulation by nicotinic receptors for cognitive processes. |
| Q33938764 | Proteomic analysis of an alpha7 nicotinic acetylcholine receptor interactome |
| Q30392403 | R-(+) and S-(-) isomers of cotinine augment cholinergic responses in vitro and in vivo |
| Q42721778 | Radioligand binding characterization of neuronal nicotinic acetylcholine receptors |
| Q37148710 | Receptor and channel heteromers as pain targets |
| Q30395065 | Replicated Risk Nicotinic Cholinergic Receptor Genes for Nicotine Dependence |
| Q37187599 | Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release |
| Q30495752 | Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice |
| Q88561566 | Stoichiometry of the Heteromeric Nicotinic Receptors of the Renshaw Cell |
| Q34782188 | Structural answers and persistent questions about how nicotinic receptors work |
| Q33738559 | Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation. |
| Q33955964 | Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation. |
| Q55515264 | Synthesis, Structure and Biological Activity of CIA and CIB, Two α-Conotoxins from the Predation-Evoked Venom of Conus catus. |
| Q37916643 | Targeting nicotinic receptors for Parkinson's disease therapy |
| Q34359550 | Tethered Agonist Analogs as Site-Specific Probes for Domains of the Human α7 Nicotinic Acetylcholine Receptor that Differentially Regulate Activation and Desensitization |
| Q37942053 | The CHRNA5-A3-B4 gene cluster in nicotine addiction |
| Q51299120 | The E Loop of the Transmitter Binding Site Is a Key Determinant of the Modulatory Effects of Physostigmine on Neuronal Nicotinic α4β2 Receptors. |
| Q37021273 | The effect of prenatal nicotine on expression of nicotine receptor subunits in the fetal brain |
| Q35801503 | The effects of nicotine on the human electroretinogram |
| Q26821785 | The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function |
| Q34126960 | The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: dual role in nicotine addiction and lung cancer |
| Q37405388 | The nicotinic α5 subunit can replace either an acetylcholine-binding or nonbinding subunit in the α4β2* neuronal nicotinic receptor |
| Q38090678 | The potential of neuronal nicotinic acetylcholine receptor agonists for treating CNS conditions |
| Q38365379 | The role of nicotinic acetylcholine receptors in autosomal dominant nocturnal frontal lobe epilepsy |
| Q37789790 | The structural basis of function in Cys-loop receptors. |
| Q42472318 | The α2-subunit of the nicotinic cholinergic receptor is specifically expressed in medial subpallium-derived cells of mammalian amygdala |
| Q40392015 | The α3β4* nicotinic acetylcholine receptor subtype mediates nicotine reward and physical nicotine withdrawal signs independently of the α5 subunit in the mouse |
| Q34837643 | The α5 subunit regulates the expression and function of α4*-containing neuronal nicotinic acetylcholine receptors in the ventral-tegmental area |
| Q30442195 | The β2 nicotinic acetylcholine receptor subunit differentially influences ethanol behavioral effects in the mouse |
| Q38525254 | Therapeutic conotoxins: a US patent literature survey |
| Q52590407 | Therapeutic potential of multifunctional tacrine analogues. |
| Q43265406 | Tonic modulation of GABA release by nicotinic acetylcholine receptors in layer V of the murine prefrontal cortex |
| Q38435927 | Unorthodox Acetylcholine Binding Sites Formed by α5 and β3 Accessory Subunits in α4β2* Nicotinic Acetylcholine Receptors |
| Q49335818 | Venom based neural modulators |
| Q45424062 | Young Human Cholinergic Neurons Respond to Physiological Regulators and Improve Cognitive Symptoms in an Animal Model of Alzheimer's Disease |
| Q37387341 | Zebrafish: a model for the study of addiction genetics |
| Q35186645 | Zinc-permeable ion channels: effects on intracellular zinc dynamics and potential physiological/pathophysiological significance |
| Q33349481 | alpha4beta2 Nicotinic acetylcholine receptors, willing if able |
| Q35588867 | α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6β4 and α6β2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release |
| Q39287268 | α-Conotoxins active at α3-containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition. |
| Q35264378 | α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease |
Search more.